A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 113.29
GOOG 630.38
MSFT 43.93
FB 91.01
BAC 16.36

Recently Added

GS 187.75
QID 35.07
SDS 22.01
CNFR 10.40
CAI 12.60

Gaining Speed

SDS 22.01
QID 35.07
TVIX 13.80
CPA 52.11
GS 187.75

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!